![]() | |
Cipla | |
Formerly | Chemical Industrial & Pharmaceutical Laboratories Ltd. (1935–1984) |
Company type | Public |
BSE: 500087 NSE: CIPLA NSE NIFTY 50 constituent | |
ISIN | INE059A01026 |
Industry | Pharmaceuticals |
Founded | 1935 |
Founder | Khwaja Abdul Hamied |
Headquarters | Mumbai, Maharashtra, India |
Area served | Worldwide |
Key people |
|
Products | |
Revenue | ![]() |
![]() | |
![]() | |
Total assets | ![]() |
Total equity | ![]() |
Number of employees | 22,036[2] |
Subsidiaries | Invagen Pharmaceuticals |
Website | www.cipla.com |
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions.[3] Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.[4][5]
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search